(firstQuint)A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia.

 The primary objectives of the study are: 1.

 To confirm the feasibility of study-related activities and the tolerability of a modified dosage regimen of AMG0001 in CLI 2.

 To evaluate safety of AMG0001.

 A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia@highlight

The purpose of the study is to confirm the feasibility of study procedures and the tolerability of a new dose regimen of AMG0001 in subjects with Critical Limb Ischemia (CLI)